A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes
PHASE2CompletedINTERVENTIONAL
Enrollment
38
Participants
Timeline
Start Date
April 30, 2000
Study Completion Date
May 31, 2002
Conditions
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Interventions
DRUG
topiramate
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00236626 - A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter